Drug for treating viral respiratory infection and pneumonia

A respiratory and viral technology, which is applied in the field of drug preparation, can solve the problems of few suitable people, side effects, and sudden diseases that cannot be well prevented and treated, and achieve definite curative effect, good curative effect, safety and no side effects Effect

Inactive Publication Date: 2020-08-11
楚雄彝族自治州中医医院
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Existing drugs, especially chemical drugs, have the following problems in the treatment and control of the disease: slow effect,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A medicine for treating viral respiratory infection and pneumonia, comprising main medicine and dispensing medicine. The main medicines include: Rhizoma praecox, Speranthum, Camphor Root, Cinnamon, Tongjiaoweiling, Polygonum, Artemisia annua, Verbena, Reed Rhizome, Yangcao, Imperata Rhizome, Agrimony, and Thousand Grass Rice. The prescription includes: calamus calamus, kudzu root, mulberry leaves, asparagus, Liangwang tea, Chuanmutong, mangzhonghua, Fangji, Jiyateng, large thistle, knotweed, honeysuckle, and prunella vulgaris.

[0020] In terms of parts by mass, the main ingredients include: 20 parts of Rhododendron chinensis, 10 parts of Sperantosporum, 10 parts of camphor root, 10 parts of Xiangpi, 20 parts of Tongjiaweiling, 10 parts of Polygonum, 10 parts of Artemisia annua , 10 parts of verbena, 10 parts of reed root, 20 parts of weed grass, 20 parts of imperina root, 20 parts of Agrimony, and 20 parts of thousand grains of rice.

[0021] In terms of parts by mass...

Embodiment 2

[0023] A medicine for treating viral respiratory infection and pneumonia, comprising main medicine and dispensing medicine. The main medicines include: Rhizoma praecox, Speranthum, Camphor Root, Cinnamon, Tongjiaoweiling, Polygonum, Artemisia annua, Verbena, Reed Rhizome, Yangcao, Imperata Rhizome, Agrimony, and Thousand Grass Rice. The prescription includes: calamus calamus, kudzu root, mulberry leaves, asparagus, Liangwang tea, Chuanmutong, mangzhonghua, Fangji, Jiyateng, large thistle, knotweed, honeysuckle, and prunella vulgaris.

[0024] In terms of parts by mass, the main ingredients include: 25 parts of Rhododendron chinensis, 15 parts of Speranthum cerevisiae, 15 parts of camphor root, 15 parts of Xiangpi, 25 parts of Tongjiaweiling, 15 parts of Polygonum officinalis, 15 parts of Artemisia annua , 25 parts of verbena, 25 parts of reed root, 25 parts of weed grass, 25 parts of imperina root, 25 parts of agrimony, and 25 parts of thousand grains of rice.

[0025] In ter...

Embodiment 3

[0027] A medicine for treating viral respiratory infection and pneumonia, comprising main medicine and dispensing medicine. The main medicines include: Rhizoma praecox, Speranthum, Camphor Root, Cinnamon, Tongjiaoweiling, Polygonum, Artemisia annua, Verbena, Reed Rhizome, Yangcao, Imperata Rhizome, Agrimony, and Thousand Grass Rice. The prescription includes: calamus calamus, kudzu root, mulberry leaves, asparagus, Liangwang tea, Chuanmutong, mangzhonghua, Fangji, Jiyateng, large thistle, knotweed, honeysuckle, and prunella vulgaris.

[0028] In terms of parts by mass, the main ingredients include: 15 parts of Rhizoma chinensis, 5 parts of Speranthum sativa, 5 parts of camphor root, 5 parts of Xiangpi, 15 parts of Tongjiaweiling, 5 parts of Polygonum, and 5 parts of Artemisia annua , 15 parts of verbena, 15 parts of reed root, 15 parts of weed grass, 15 parts of imperina root, 15 parts of agrimony, and 15 parts of thousand grains of rice.

[0029] In terms of parts by mass, t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a drug for treating viral respiratory infection and pneumonia in order to overcome defects in the prior art. The drug comprises a main drug and an auxiliary drug, wherein the main drug comprises components as follows: elsholtzia rugulosa, garden balsam stem, root of camphorwood, osyris wightiana, root of clematis terniflora, herba polygoni hydropiperis, sweet wormwood herb,verbena officinalis, rhizoma phragmitis, medicago hispida,, rhizoma imperatae, herba agrimoniae and twig and leaf of taperleaf japanese spiraea; and the auxiliary drug comprises components as follows:rhizoma acori graminei, pueraria thomsonii, folium mori, radix asparagi, nothopanax davidii, caulis clematidis armandii, goldencup hypericum, radix stephaniae tetrandrae, paederia scandens, herba cirsii japonici, rhizoma polygoni cuspidati, caulis lonicerae and spica prunellae. The drug has effects of relieving exterior syndrome, descending turbidity and being antipyretic and antitoxic, and is mainly used for treating lung-defense syndrome caused by toxic factors. After a large number of trials, the drug has a curative effect, is safe and free of toxic and side effects, and has better curative effect on pneumonia patients infected with novel coronavirus.

Description

technical field [0001] The invention belongs to the technical field of medicine preparation, and in particular relates to a medicine for treating viral respiratory tract infection and pneumonia. Background technique [0002] Viral respiratory infection is the most common clinical respiratory infection. Common symptoms include cough, white sputum, high fever, headache, and joint pain all over the body. Some of these viruses can also attack the lungs and cause pneumonia. Among them, Corona Virus Disease 2019 (COVID-19) is also a sudden-onset disease in which respiratory tract infections caused by viruses lead to pneumonia. Existing drugs, especially chemical drugs, have the following problems in the treatment and control of the disease: slow effect, less suitable people and some side effects, which cannot play a good role in the prevention and treatment of the sudden disease. Contents of the invention [0003] Aiming at the deficiencies in the prior art, the invention provi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/899A61P11/00A61P31/14
CPCA61K36/185A61K36/25A61K36/28A61K36/282A61K36/355A61K36/38A61K36/47A61K36/488A61K36/53A61K36/536A61K36/54A61K36/59A61K36/605A61K36/704A61K36/716A61K36/73A61K36/74A61K36/85A61K36/88A61K36/888A61K36/8965A61K36/899A61P11/00A61P31/14A61K2300/00
Inventor 张之道张勇进许嘉鹏
Owner 楚雄彝族自治州中医医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products